General Announcement::Press Release

Issuer & Securities

Issuer/ Manager
BIOCON BIOLOGICS GLOBAL PLC
Securities
BIOCONBIO US$800M6.67%N291009A - US090978AA56 - RJUB
BIOCONBIO US$800M6.67%N291009R - USG11185AA61 - KSEB
Stapled Security
No

Announcement Details

Announcement Title
General Announcement
Date &Time of Broadcast
02-Dec-2025 11:44:29
Status
New
Announcement Sub Title
Press Release
Announcement Reference
SG251202OTHRR6QG
Submitted By (Co./ Ind. Name)
Biocon Biologics Limited/ Akhilesh Nand
Designation
Company Secretary
Effective Date and Time of the event
02/12/2025 09:00:00
Description (Please provide a detailed description of the event in the box below)
Biocon Biologics Secures Market Entry Date for Denosumab Biosimilars in Europe and Rest of the World

Attachments

Biocon Biologics_Denosumab_Settlement_2.12.2025_PR_SGX.pdf
Total size =321K